

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive T cell selection (GO:0043368) | 5.41436082 |
| 2 | positive thymic T cell selection (GO:0045059) | 5.37239996 |
| 3 | regulation of glycogen (starch) synthase activity (GO:2000465) | 4.87333472 |
| 4 | positive regulation of Rap GTPase activity (GO:0032854) | 4.85036970 |
| 5 | nerve growth factor signaling pathway (GO:0038180) | 4.70061587 |
| 6 | positive regulation of vasculogenesis (GO:2001214) | 4.63563599 |
| 7 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.61004302 |
| 8 | positive regulation of granulocyte differentiation (GO:0030854) | 4.23255361 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.22747020 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.22747020 |
| 11 | regulation of Rap GTPase activity (GO:0032317) | 4.20733240 |
| 12 | negative thymic T cell selection (GO:0045060) | 4.12859372 |
| 13 | Rap protein signal transduction (GO:0032486) | 4.12676891 |
| 14 | embryonic process involved in female pregnancy (GO:0060136) | 4.09403692 |
| 15 | adaptation of signaling pathway (GO:0023058) | 4.06584437 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.05850453 |
| 17 | T cell selection (GO:0045058) | 4.04272348 |
| 18 | viral transcription (GO:0019083) | 4.02596410 |
| 19 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.92375363 |
| 20 | negative T cell selection (GO:0043383) | 3.87740299 |
| 21 | negative regulation of T cell mediated immunity (GO:0002710) | 3.86525779 |
| 22 | thymic T cell selection (GO:0045061) | 3.83669060 |
| 23 | negative regulation of neurotransmitter transport (GO:0051589) | 3.83033630 |
| 24 | regulation of establishment of cell polarity (GO:2000114) | 3.82401347 |
| 25 | embryonic hemopoiesis (GO:0035162) | 3.79515059 |
| 26 | translational termination (GO:0006415) | 3.71086980 |
| 27 | histone H3-K4 trimethylation (GO:0080182) | 3.65365718 |
| 28 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.61958570 |
| 29 | rRNA methylation (GO:0031167) | 3.55234238 |
| 30 | definitive hemopoiesis (GO:0060216) | 3.54382935 |
| 31 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.54348744 |
| 32 | positive regulation of tolerance induction (GO:0002645) | 3.47947803 |
| 33 | response to nerve growth factor (GO:1990089) | 3.45557587 |
| 34 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.45557587 |
| 35 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.40672880 |
| 36 | rRNA modification (GO:0000154) | 3.40447911 |
| 37 | activated T cell proliferation (GO:0050798) | 3.38253819 |
| 38 | mast cell degranulation (GO:0043303) | 3.31491509 |
| 39 | mast cell activation involved in immune response (GO:0002279) | 3.31491509 |
| 40 | megakaryocyte development (GO:0035855) | 3.30066009 |
| 41 | negative regulation of granulocyte differentiation (GO:0030853) | 3.29732785 |
| 42 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.29456343 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.27132309 |
| 44 | negative regulation of muscle hypertrophy (GO:0014741) | 3.20365784 |
| 45 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.16730979 |
| 46 | mRNA splice site selection (GO:0006376) | 3.15646567 |
| 47 | regulation of granulocyte differentiation (GO:0030852) | 3.13670449 |
| 48 | C21-steroid hormone biosynthetic process (GO:0006700) | 3.11333672 |
| 49 | translational elongation (GO:0006414) | 3.09876181 |
| 50 | response to peptidoglycan (GO:0032494) | 3.07428356 |
| 51 | neurotransmitter biosynthetic process (GO:0042136) | 3.07000875 |
| 52 | eyelid development in camera-type eye (GO:0061029) | 3.06189016 |
| 53 | histone H3-K9 modification (GO:0061647) | 3.05206469 |
| 54 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.03452265 |
| 55 | regulation of gamma-delta T cell activation (GO:0046643) | 2.98131167 |
| 56 | energy homeostasis (GO:0097009) | 2.97903223 |
| 57 | cellular extravasation (GO:0045123) | 2.96873126 |
| 58 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.95280106 |
| 59 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.94105338 |
| 60 | mast cell activation (GO:0045576) | 2.93001110 |
| 61 | tolerance induction (GO:0002507) | 2.92734228 |
| 62 | regulation of tolerance induction (GO:0002643) | 2.91120886 |
| 63 | positive regulation of protein homooligomerization (GO:0032464) | 2.90573008 |
| 64 | viral life cycle (GO:0019058) | 2.90018952 |
| 65 | B cell receptor signaling pathway (GO:0050853) | 2.88251532 |
| 66 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.87153668 |
| 67 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.82415501 |
| 68 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.81626579 |
| 69 | establishment of endothelial barrier (GO:0061028) | 2.81200268 |
| 70 | cellular protein complex disassembly (GO:0043624) | 2.78582260 |
| 71 | response to interleukin-15 (GO:0070672) | 2.78300734 |
| 72 | negative regulation of interleukin-12 production (GO:0032695) | 2.77580740 |
| 73 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.77266662 |
| 74 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.77089476 |
| 75 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.76004910 |
| 76 | positive regulation by host of viral transcription (GO:0043923) | 2.75554115 |
| 77 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.74717228 |
| 78 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.72060129 |
| 79 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.70696107 |
| 80 | T cell migration (GO:0072678) | 2.69422596 |
| 81 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.66549858 |
| 82 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.66087676 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.66087676 |
| 84 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.65344188 |
| 85 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.64574471 |
| 86 | granulocyte differentiation (GO:0030851) | 2.64475738 |
| 87 | neural tube formation (GO:0001841) | 2.64152231 |
| 88 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.64133394 |
| 89 | regulation of vasculogenesis (GO:2001212) | 2.61009623 |
| 90 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.60473931 |
| 91 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.60344168 |
| 92 | regulation of B cell differentiation (GO:0045577) | 2.60047628 |
| 93 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.59681639 |
| 94 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.58481584 |
| 95 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.58171256 |
| 96 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.57525602 |
| 97 | detection of bacterium (GO:0016045) | 2.55516320 |
| 98 | cotranslational protein targeting to membrane (GO:0006613) | 2.55029530 |
| 99 | negative regulation of type 2 immune response (GO:0002829) | 2.52932852 |
| 100 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.50803647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.49710546 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.82113349 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.30467703 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 4.27608946 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.14957281 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.29301290 |
| 7 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.05056651 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.89922172 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.74328326 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.65671454 |
| 11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.59234303 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.58991872 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.56211417 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.43634888 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.42464188 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.36319417 |
| 17 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.35957467 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.31877263 |
| 19 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.28302938 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.20500559 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.20115121 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04973996 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 2.01606857 |
| 24 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01576596 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.01501090 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 1.95214190 |
| 27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95024609 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94251581 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93830875 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.84608052 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77910142 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64813312 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.62673146 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60350459 |
| 35 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.55873174 |
| 36 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.55041277 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.50876409 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.48753602 |
| 39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44020401 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40991130 |
| 41 | GATA3_26560356_Chip-Seq_TH2_Human | 1.35945648 |
| 42 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33824334 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27227690 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26625122 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25254759 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24058582 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.23306913 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21824234 |
| 49 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.18359570 |
| 50 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.18359570 |
| 51 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.18359570 |
| 52 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17958036 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17597365 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15111406 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14003253 |
| 56 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13384669 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12799986 |
| 58 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.12218296 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09535598 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09303030 |
| 61 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.07735099 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05716909 |
| 63 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04008339 |
| 64 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.03668760 |
| 65 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.03019814 |
| 66 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02953895 |
| 67 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00678891 |
| 68 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.00047385 |
| 69 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99270190 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97687336 |
| 71 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.97265806 |
| 72 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.96059958 |
| 73 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.94122116 |
| 74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.93616758 |
| 75 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93041069 |
| 76 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92343627 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91509217 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91501821 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91369220 |
| 80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90450628 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90090047 |
| 82 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.89997707 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89369014 |
| 84 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89075154 |
| 85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87685773 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84357512 |
| 87 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.84313659 |
| 88 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84080188 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82725010 |
| 90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82505859 |
| 91 | EWS_26573619_Chip-Seq_HEK293_Human | 0.81718626 |
| 92 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.80614405 |
| 93 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.78756553 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78528500 |
| 95 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.78479945 |
| 96 | FUS_26573619_Chip-Seq_HEK293_Human | 0.77074570 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.76901132 |
| 98 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.76722588 |
| 99 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.76361145 |
| 100 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.75186646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 8.40827133 |
| 2 | MP0005451_abnormal_body_composition | 4.10795838 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.95331087 |
| 4 | MP0003724_increased_susceptibility_to | 3.69779132 |
| 5 | MP0008260_abnormal_autophagy | 3.27062896 |
| 6 | MP0009379_abnormal_foot_pigmentation | 2.95650514 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.67564411 |
| 8 | MP0003436_decreased_susceptibility_to | 2.47797869 |
| 9 | MP0000685_abnormal_immune_system | 2.39734722 |
| 10 | MP0009278_abnormal_bone_marrow | 2.34704398 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.34423454 |
| 12 | MP0005397_hematopoietic_system_phenotyp | 2.29334817 |
| 13 | MP0001545_abnormal_hematopoietic_system | 2.29334817 |
| 14 | MP0003880_abnormal_central_pattern | 2.24148281 |
| 15 | MP0001800_abnormal_humoral_immune | 2.09213058 |
| 16 | MP0001790_abnormal_immune_system | 1.98268085 |
| 17 | MP0005387_immune_system_phenotype | 1.98268085 |
| 18 | MP0004142_abnormal_muscle_tone | 1.97906988 |
| 19 | MP0005464_abnormal_platelet_physiology | 1.96615954 |
| 20 | MP0002166_altered_tumor_susceptibility | 1.86692229 |
| 21 | MP0002102_abnormal_ear_morphology | 1.84166322 |
| 22 | MP0001188_hyperpigmentation | 1.78263050 |
| 23 | MP0004808_abnormal_hematopoietic_stem | 1.76791304 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 1.75591937 |
| 25 | MP0002398_abnormal_bone_marrow | 1.67597982 |
| 26 | MP0000013_abnormal_adipose_tissue | 1.64677878 |
| 27 | MP0002723_abnormal_immune_serum | 1.62733496 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.62635398 |
| 29 | MP0002420_abnormal_adaptive_immunity | 1.55303126 |
| 30 | MP0001819_abnormal_immune_cell | 1.52914556 |
| 31 | MP0004147_increased_porphyrin_level | 1.52755733 |
| 32 | MP0003252_abnormal_bile_duct | 1.50143999 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.45744293 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.45463455 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.44355410 |
| 36 | MP0005671_abnormal_response_to | 1.42907668 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.42741784 |
| 38 | MP0002006_tumorigenesis | 1.39798394 |
| 39 | MP0003303_peritoneal_inflammation | 1.39280381 |
| 40 | MP0008877_abnormal_DNA_methylation | 1.39204711 |
| 41 | MP0005025_abnormal_response_to | 1.38471324 |
| 42 | MP0003828_pulmonary_edema | 1.38108340 |
| 43 | MP0000716_abnormal_immune_system | 1.36431690 |
| 44 | MP0009697_abnormal_copulation | 1.27901629 |
| 45 | MP0002009_preneoplasia | 1.24392667 |
| 46 | MP0002722_abnormal_immune_system | 1.21085204 |
| 47 | MP0009764_decreased_sensitivity_to | 1.19542059 |
| 48 | MP0002419_abnormal_innate_immunity | 1.16327015 |
| 49 | MP0003300_gastrointestinal_ulcer | 1.15803343 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.14281503 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.13554264 |
| 52 | MP0005409_darkened_coat_color | 1.09448938 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.09067391 |
| 54 | MP0005535_abnormal_body_temperature | 1.04711033 |
| 55 | MP0002429_abnormal_blood_cell | 1.03262122 |
| 56 | MP0000015_abnormal_ear_pigmentation | 1.03246660 |
| 57 | MP0003878_abnormal_ear_physiology | 1.01581072 |
| 58 | MP0005377_hearing/vestibular/ear_phenot | 1.01581072 |
| 59 | MP0005310_abnormal_salivary_gland | 0.99486766 |
| 60 | MP0004484_altered_response_of | 0.93381027 |
| 61 | MP0003172_abnormal_lysosome_physiology | 0.93357287 |
| 62 | MP0001986_abnormal_taste_sensitivity | 0.90877490 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 0.89729056 |
| 64 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89208887 |
| 65 | MP0004084_abnormal_cardiac_muscle | 0.84727414 |
| 66 | MP0002405_respiratory_system_inflammati | 0.83267424 |
| 67 | MP0003866_abnormal_defecation | 0.77642183 |
| 68 | MP0010155_abnormal_intestine_physiology | 0.77385940 |
| 69 | MP0008873_increased_physiological_sensi | 0.77348491 |
| 70 | MP0005166_decreased_susceptibility_to | 0.75738030 |
| 71 | MP0009785_altered_susceptibility_to | 0.73409961 |
| 72 | MP0004134_abnormal_chest_morphology | 0.73394319 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 0.71669639 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 0.70834526 |
| 75 | MP0002108_abnormal_muscle_morphology | 0.70343770 |
| 76 | MP0008995_early_reproductive_senescence | 0.69285805 |
| 77 | MP0000249_abnormal_blood_vessel | 0.65741152 |
| 78 | MP0002998_abnormal_bone_remodeling | 0.64311919 |
| 79 | MP0004130_abnormal_muscle_cell | 0.63619023 |
| 80 | MP0000604_amyloidosis | 0.63543065 |
| 81 | MP0004947_skin_inflammation | 0.62448896 |
| 82 | MP0008872_abnormal_physiological_respon | 0.62136199 |
| 83 | MP0006276_abnormal_autonomic_nervous | 0.61455117 |
| 84 | MP0002019_abnormal_tumor_incidence | 0.59041409 |
| 85 | MP0001663_abnormal_digestive_system | 0.57327485 |
| 86 | MP0005174_abnormal_tail_pigmentation | 0.57086633 |
| 87 | MP0003959_abnormal_lean_body | 0.56958289 |
| 88 | MP0004883_abnormal_blood_vessel | 0.56955313 |
| 89 | MP0001727_abnormal_embryo_implantation | 0.56288862 |
| 90 | MP0006292_abnormal_olfactory_placode | 0.55939433 |
| 91 | MP0002269_muscular_atrophy | 0.55607315 |
| 92 | MP0001845_abnormal_inflammatory_respons | 0.54759052 |
| 93 | MP0005408_hypopigmentation | 0.53825848 |
| 94 | MP0000858_altered_metastatic_potential | 0.52980523 |
| 95 | MP0004885_abnormal_endolymph | 0.52974328 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.52748924 |
| 97 | MP0009115_abnormal_fat_cell | 0.52331702 |
| 98 | MP0005448_abnormal_energy_balance | 0.49726044 |
| 99 | MP0001851_eye_inflammation | 0.49379246 |
| 100 | MP0005390_skeleton_phenotype | 0.49025152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 2 muscle fiber atrophy (HP:0003554) | 7.34917021 |
| 2 | Stomatitis (HP:0010280) | 6.99229031 |
| 3 | Muscle fiber atrophy (HP:0100295) | 6.62836371 |
| 4 | Fatigable weakness (HP:0003473) | 5.02651605 |
| 5 | Abnormality of the neuromuscular junction (HP:0003398) | 5.02651605 |
| 6 | Weak cry (HP:0001612) | 4.98387400 |
| 7 | Papilledema (HP:0001085) | 4.38677561 |
| 8 | Increased IgM level (HP:0003496) | 4.08365888 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.06230140 |
| 10 | Prolonged bleeding time (HP:0003010) | 3.98211438 |
| 11 | Myositis (HP:0100614) | 3.85018876 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.82725274 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 3.55966072 |
| 14 | Bulbar palsy (HP:0001283) | 3.32396123 |
| 15 | Fatigue (HP:0012378) | 3.29810569 |
| 16 | Distal arthrogryposis (HP:0005684) | 3.17450727 |
| 17 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.01601615 |
| 18 | Poor suck (HP:0002033) | 2.99993252 |
| 19 | Pustule (HP:0200039) | 2.97595871 |
| 20 | Spinal cord lesions (HP:0100561) | 2.92253603 |
| 21 | Syringomyelia (HP:0003396) | 2.92253603 |
| 22 | Abnormality of the periventricular white matter (HP:0002518) | 2.88019480 |
| 23 | Acute myeloid leukemia (HP:0004808) | 2.83392746 |
| 24 | Epistaxis (HP:0000421) | 2.71519803 |
| 25 | Abnormality of T cell physiology (HP:0011840) | 2.70273344 |
| 26 | Abnormal number of erythroid precursors (HP:0012131) | 2.64371392 |
| 27 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.55223774 |
| 28 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.52750681 |
| 29 | Subaortic stenosis (HP:0001682) | 2.52750681 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 2.52741271 |
| 31 | Abnormality of T cells (HP:0002843) | 2.51398570 |
| 32 | Gingival bleeding (HP:0000225) | 2.46238019 |
| 33 | Hypergammaglobulinemia (HP:0010702) | 2.43965051 |
| 34 | IgG deficiency (HP:0004315) | 2.40604612 |
| 35 | Intellectual disability, profound (HP:0002187) | 2.40481379 |
| 36 | Eczematoid dermatitis (HP:0000976) | 2.37508815 |
| 37 | Generalized hypotonia (HP:0001290) | 2.32332161 |
| 38 | Peritonitis (HP:0002586) | 2.27457350 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.25465136 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23988740 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23988740 |
| 42 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.23558781 |
| 43 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.23558781 |
| 44 | Pallor (HP:0000980) | 2.20806512 |
| 45 | Polycythemia (HP:0001901) | 2.20138350 |
| 46 | Recurrent bacterial skin infections (HP:0005406) | 2.17758577 |
| 47 | Basal cell carcinoma (HP:0002671) | 2.17431062 |
| 48 | Facial diplegia (HP:0001349) | 2.15997124 |
| 49 | Meningitis (HP:0001287) | 2.15250269 |
| 50 | Macrocytic anemia (HP:0001972) | 2.14618513 |
| 51 | Mesomelia (HP:0003027) | 2.14127470 |
| 52 | Aortic aneurysm (HP:0004942) | 2.11772690 |
| 53 | Agammaglobulinemia (HP:0004432) | 2.10343067 |
| 54 | Frequent falls (HP:0002359) | 2.08417744 |
| 55 | Clonus (HP:0002169) | 2.07186445 |
| 56 | Abnormality of incisor morphology (HP:0011063) | 2.05303694 |
| 57 | Recurrent skin infections (HP:0001581) | 2.04490708 |
| 58 | Broad alveolar ridges (HP:0000187) | 2.01140753 |
| 59 | Thrombocytosis (HP:0001894) | 2.01075711 |
| 60 | Parakeratosis (HP:0001036) | 1.98578693 |
| 61 | Recurrent fungal infections (HP:0002841) | 1.98537590 |
| 62 | Abnormality of the 2nd finger (HP:0004100) | 1.95931884 |
| 63 | Leukocytosis (HP:0001974) | 1.95365523 |
| 64 | Rimmed vacuoles (HP:0003805) | 1.93200731 |
| 65 | Tapered finger (HP:0001182) | 1.91456526 |
| 66 | T lymphocytopenia (HP:0005403) | 1.85446077 |
| 67 | Narrow palate (HP:0000189) | 1.82581818 |
| 68 | Inflammation of the large intestine (HP:0002037) | 1.80977130 |
| 69 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.77750147 |
| 70 | Recurrent abscess formation (HP:0002722) | 1.77294865 |
| 71 | Pulmonary embolism (HP:0002204) | 1.76234724 |
| 72 | Constricted visual fields (HP:0001133) | 1.76205436 |
| 73 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.75960905 |
| 74 | Recurrent viral infections (HP:0004429) | 1.75751858 |
| 75 | Osteomyelitis (HP:0002754) | 1.73351736 |
| 76 | Stomach cancer (HP:0012126) | 1.70356275 |
| 77 | Encephalitis (HP:0002383) | 1.69946343 |
| 78 | IgM deficiency (HP:0002850) | 1.69283428 |
| 79 | Broad palm (HP:0001169) | 1.69214317 |
| 80 | Abnormal platelet function (HP:0011869) | 1.68589064 |
| 81 | Impaired platelet aggregation (HP:0003540) | 1.68589064 |
| 82 | Aplastic anemia (HP:0001915) | 1.68373951 |
| 83 | Abnormality of T cell number (HP:0011839) | 1.68114805 |
| 84 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.67356726 |
| 85 | Tinnitus (HP:0000360) | 1.67340090 |
| 86 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.66988677 |
| 87 | Mediastinal lymphadenopathy (HP:0100721) | 1.65964863 |
| 88 | Disproportionate short-trunk short stature (HP:0003521) | 1.65656551 |
| 89 | Submucous cleft hard palate (HP:0000176) | 1.65100552 |
| 90 | Capillary hemangiomas (HP:0005306) | 1.64684407 |
| 91 | Respiratory distress (HP:0002098) | 1.63904023 |
| 92 | Gastrointestinal inflammation (HP:0004386) | 1.63219705 |
| 93 | Chest pain (HP:0100749) | 1.63001063 |
| 94 | Papilloma (HP:0012740) | 1.62876916 |
| 95 | Verrucae (HP:0200043) | 1.62876916 |
| 96 | Vasculitis (HP:0002633) | 1.61934652 |
| 97 | Retrobulbar optic neuritis (HP:0100654) | 1.60220448 |
| 98 | Optic neuritis (HP:0100653) | 1.60220448 |
| 99 | Lower limb asymmetry (HP:0100559) | 1.57981597 |
| 100 | Neutropenia (HP:0001875) | 1.57812738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 5.04577966 |
| 2 | SIK1 | 3.91392126 |
| 3 | TAOK3 | 3.55263095 |
| 4 | SIK2 | 3.36982956 |
| 5 | MAP3K6 | 3.13696323 |
| 6 | PRPF4B | 2.73903456 |
| 7 | MAP4K1 | 2.65125892 |
| 8 | JAK3 | 2.55389022 |
| 9 | DYRK3 | 2.42515084 |
| 10 | MAP3K4 | 2.39644679 |
| 11 | PIK3CG | 2.36004138 |
| 12 | AKT3 | 1.98085453 |
| 13 | MAP3K10 | 1.97886817 |
| 14 | MARK3 | 1.88806134 |
| 15 | RIPK4 | 1.88800612 |
| 16 | PRKCH | 1.69746287 |
| 17 | FGFR3 | 1.67075136 |
| 18 | SGK2 | 1.64544569 |
| 19 | MAP2K7 | 1.63819989 |
| 20 | MAP2K4 | 1.63329828 |
| 21 | ZAK | 1.50681242 |
| 22 | PASK | 1.39616909 |
| 23 | TXK | 1.35568403 |
| 24 | CDK6 | 1.23931574 |
| 25 | IKBKE | 1.23490766 |
| 26 | ADRBK2 | 1.14494154 |
| 27 | MAP3K13 | 1.11768136 |
| 28 | IRAK4 | 1.11502186 |
| 29 | KIT | 1.10749058 |
| 30 | ITK | 1.08548316 |
| 31 | MAPKAPK3 | 1.07959538 |
| 32 | CSNK1G3 | 1.06789336 |
| 33 | FES | 1.05004529 |
| 34 | PRKD2 | 1.03375661 |
| 35 | SGK494 | 0.98062906 |
| 36 | SGK223 | 0.98062906 |
| 37 | IRAK1 | 0.96373661 |
| 38 | SGK3 | 0.95485059 |
| 39 | TYRO3 | 0.94360718 |
| 40 | PINK1 | 0.93564619 |
| 41 | CCNB1 | 0.92916879 |
| 42 | RPS6KC1 | 0.91611957 |
| 43 | RPS6KL1 | 0.91611957 |
| 44 | JAK1 | 0.91320928 |
| 45 | FRK | 0.88923621 |
| 46 | RPS6KA6 | 0.86809410 |
| 47 | CSNK1G2 | 0.86120673 |
| 48 | MARK2 | 0.85443973 |
| 49 | HIPK2 | 0.84327211 |
| 50 | DAPK2 | 0.83370291 |
| 51 | MAP2K3 | 0.81802303 |
| 52 | SYK | 0.81447518 |
| 53 | TYK2 | 0.81120994 |
| 54 | MAP3K14 | 0.81083604 |
| 55 | KSR2 | 0.78729434 |
| 56 | BTK | 0.76608044 |
| 57 | RPS6KA2 | 0.75309272 |
| 58 | LCK | 0.71605963 |
| 59 | PTK6 | 0.70150740 |
| 60 | CSNK1G1 | 0.69951825 |
| 61 | UHMK1 | 0.69383752 |
| 62 | MAP3K5 | 0.68896969 |
| 63 | CSNK1A1L | 0.67761246 |
| 64 | BRD4 | 0.67309165 |
| 65 | CSK | 0.64687861 |
| 66 | TEC | 0.63419876 |
| 67 | JAK2 | 0.63148627 |
| 68 | MAPK15 | 0.62206641 |
| 69 | HCK | 0.59422803 |
| 70 | ZAP70 | 0.59148304 |
| 71 | MATK | 0.59032907 |
| 72 | KSR1 | 0.58433144 |
| 73 | LYN | 0.58373261 |
| 74 | GRK6 | 0.57376281 |
| 75 | MAP3K2 | 0.54832218 |
| 76 | IKBKB | 0.54377002 |
| 77 | CSF1R | 0.53755838 |
| 78 | BMPR2 | 0.53243006 |
| 79 | LATS1 | 0.52198446 |
| 80 | PRKCG | 0.51864768 |
| 81 | PRKCE | 0.51246494 |
| 82 | TBK1 | 0.48746640 |
| 83 | MAP2K1 | 0.48462001 |
| 84 | STK38L | 0.46437853 |
| 85 | MAPK12 | 0.44691966 |
| 86 | OBSCN | 0.43376946 |
| 87 | PIM1 | 0.41903852 |
| 88 | TAF1 | 0.41331676 |
| 89 | DYRK1B | 0.39643877 |
| 90 | MKNK1 | 0.39259520 |
| 91 | STK38 | 0.38303130 |
| 92 | PRKCD | 0.37363143 |
| 93 | STK24 | 0.36873094 |
| 94 | MAPK7 | 0.35723163 |
| 95 | TRPM7 | 0.35433554 |
| 96 | TGFBR1 | 0.35140208 |
| 97 | MAP3K7 | 0.34201943 |
| 98 | EPHB2 | 0.33932650 |
| 99 | BLK | 0.31410140 |
| 100 | CAMK4 | 0.30193324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 2.79038117 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 2.78568173 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.71235602 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.39893992 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.22828730 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.22531558 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.22000498 |
| 8 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.15249721 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.12333771 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.07003186 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.87599156 |
| 12 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.85685563 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.81942894 |
| 14 | Platelet activation_Homo sapiens_hsa04611 | 1.75804934 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 1.70203906 |
| 16 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.65083023 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60958320 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.58298122 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.57560137 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54639109 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47341681 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42597451 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.42195699 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.41548712 |
| 25 | Colorectal cancer_Homo sapiens_hsa05210 | 1.33867401 |
| 26 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.33673774 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33179696 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33104586 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32729360 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.31840597 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.31797571 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28300533 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.28229011 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23209440 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21654654 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.21055834 |
| 37 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.17351582 |
| 38 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17092145 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16490440 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.14598993 |
| 41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.13332271 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.08994709 |
| 43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.05116844 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98175676 |
| 45 | Long-term depression_Homo sapiens_hsa04730 | 0.97878137 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96485815 |
| 47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95770959 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93886172 |
| 49 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.93012650 |
| 50 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86930621 |
| 51 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.86266515 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.86078418 |
| 53 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85000559 |
| 54 | Endometrial cancer_Homo sapiens_hsa05213 | 0.81539850 |
| 55 | Renin secretion_Homo sapiens_hsa04924 | 0.80457683 |
| 56 | Malaria_Homo sapiens_hsa05144 | 0.78731591 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.77046284 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76797022 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75770010 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.74838161 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.74581914 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.74218883 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74197147 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74058386 |
| 65 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.72807204 |
| 66 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.72517426 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72241108 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68624131 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68582472 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68049537 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67238311 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66122534 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64500558 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63103988 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.61276537 |
| 76 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.61178401 |
| 77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61000368 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.59245577 |
| 79 | Shigellosis_Homo sapiens_hsa05131 | 0.57655634 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57318124 |
| 81 | Cocaine addiction_Homo sapiens_hsa05030 | 0.57109731 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55670238 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51372441 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51313508 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49212500 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48135586 |
| 87 | Gap junction_Homo sapiens_hsa04540 | 0.48111803 |
| 88 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47166450 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44064157 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.42887672 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42707018 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.42088704 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39677952 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.39536464 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38480820 |
| 96 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.37163961 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.36419475 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35206740 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35056915 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32684852 |

